Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients implications for the american heart association depression screening advisory

Kim G. Smolderen, Donna M. Buchanan, Alpesh A. Amin, Kensey Gosch, Karen Nugent, Lisa Riggs, Geri Seavey, John A. Spertus

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: The American Heart Association (AHA) statement has recommended routine screening for depression in coronary artery disease with a 2-stage implementation of the Patient Health Questionnaire (PHQ)Because there is little evidence on feasibility, accuracy, and impact of such a program on depression recognition in coronary patients, the AHA recommendation has met substantial debate and criticismMethods and Results: Before the AHA statement was released, the Mid America Heart and Vascular Institute (MAHVI) had implemented a depression screening protocol for patients with acute myocardial infarction that was virtually identical to the AHA recommendationsTo (1) evaluate this MAHVI quality improvement initiative, (2) compare MAHVI depression recognition rates with those of other hospitals, and (3) examine health care providers' implementation feedback, we compared the results of the MAHVI screening program with data from a parallel prospective acute myocardial infarction registry and interviewed MAHVI providersDepressive symptoms (PHQ-2, PHQ-9) were assessed among 503 MAHVI acute myocardial infarction patients and compared with concurrent depression assessments among 3533 patients at 23 US centers without a screening protocolA qualitative summary of providers' suggestions for improvement was also generatedA total of 135 (26.8%) eligible MAHVI patients did not get screenedAmong screened patients, 90.9% depressed (PHQ-9 >10) patients were recognizedThe agreement between the screening and registry data using the full PHQ-9 was 61.5% for positive cases (PHQ-9 >0) but only 35.6% for the PHQ-2 aloneAlthough MAHVI had a slightly higher overall depression recognition rate (38.3%) than other centers not using a depression screening protocol (31.5%), the difference was not statistically significant (p=0.31)Staff feedback suggested that a single-stage screening protocol with continuous feedback could improve complianceConclusions: In this early effort to implement a depression screening protocol, a large proportion of patients did not get screened, and only a modest impact on depression recognition rates was realizedSimplifying the protocol by using the PHQ-9 alone and providing more support and feedback may improve the rates of depression detection and treatment.

Original languageEnglish (US)
Pages (from-to)283-292
Number of pages10
JournalCirculation: Cardiovascular Quality and Outcomes
Volume4
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

American Heart Association
Myocardial Infarction
Blood Vessels
Health
Registries
Surveys and Questionnaires

Keywords

  • AHA medical/scientific statements
  • Myocardial infarction
  • Patient centered care
  • Rrisk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients implications for the american heart association depression screening advisory. / Smolderen, Kim G.; Buchanan, Donna M.; Amin, Alpesh A.; Gosch, Kensey; Nugent, Karen; Riggs, Lisa; Seavey, Geri; Spertus, John A.

In: Circulation: Cardiovascular Quality and Outcomes, Vol. 4, No. 3, 05.2011, p. 283-292.

Research output: Contribution to journalArticle

@article{478e3b40b0174004884e26c3b6e79af4,
title = "Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients implications for the american heart association depression screening advisory",
abstract = "Background: The American Heart Association (AHA) statement has recommended routine screening for depression in coronary artery disease with a 2-stage implementation of the Patient Health Questionnaire (PHQ)Because there is little evidence on feasibility, accuracy, and impact of such a program on depression recognition in coronary patients, the AHA recommendation has met substantial debate and criticismMethods and Results: Before the AHA statement was released, the Mid America Heart and Vascular Institute (MAHVI) had implemented a depression screening protocol for patients with acute myocardial infarction that was virtually identical to the AHA recommendationsTo (1) evaluate this MAHVI quality improvement initiative, (2) compare MAHVI depression recognition rates with those of other hospitals, and (3) examine health care providers' implementation feedback, we compared the results of the MAHVI screening program with data from a parallel prospective acute myocardial infarction registry and interviewed MAHVI providersDepressive symptoms (PHQ-2, PHQ-9) were assessed among 503 MAHVI acute myocardial infarction patients and compared with concurrent depression assessments among 3533 patients at 23 US centers without a screening protocolA qualitative summary of providers' suggestions for improvement was also generatedA total of 135 (26.8{\%}) eligible MAHVI patients did not get screenedAmong screened patients, 90.9{\%} depressed (PHQ-9 >10) patients were recognizedThe agreement between the screening and registry data using the full PHQ-9 was 61.5{\%} for positive cases (PHQ-9 >0) but only 35.6{\%} for the PHQ-2 aloneAlthough MAHVI had a slightly higher overall depression recognition rate (38.3{\%}) than other centers not using a depression screening protocol (31.5{\%}), the difference was not statistically significant (p=0.31)Staff feedback suggested that a single-stage screening protocol with continuous feedback could improve complianceConclusions: In this early effort to implement a depression screening protocol, a large proportion of patients did not get screened, and only a modest impact on depression recognition rates was realizedSimplifying the protocol by using the PHQ-9 alone and providing more support and feedback may improve the rates of depression detection and treatment.",
keywords = "AHA medical/scientific statements, Myocardial infarction, Patient centered care, Rrisk factors",
author = "Smolderen, {Kim G.} and Buchanan, {Donna M.} and Amin, {Alpesh A.} and Kensey Gosch and Karen Nugent and Lisa Riggs and Geri Seavey and Spertus, {John A.}",
year = "2011",
month = "5",
doi = "10.1161/CIRCOUTCOMES.110.960013",
language = "English (US)",
volume = "4",
pages = "283--292",
journal = "Circulation: Cardiovascular Quality and Outcomes",
issn = "1941-7713",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Real-world lessons from the implementation of a depression screening protocol in acute myocardial infarction patients implications for the american heart association depression screening advisory

AU - Smolderen, Kim G.

AU - Buchanan, Donna M.

AU - Amin, Alpesh A.

AU - Gosch, Kensey

AU - Nugent, Karen

AU - Riggs, Lisa

AU - Seavey, Geri

AU - Spertus, John A.

PY - 2011/5

Y1 - 2011/5

N2 - Background: The American Heart Association (AHA) statement has recommended routine screening for depression in coronary artery disease with a 2-stage implementation of the Patient Health Questionnaire (PHQ)Because there is little evidence on feasibility, accuracy, and impact of such a program on depression recognition in coronary patients, the AHA recommendation has met substantial debate and criticismMethods and Results: Before the AHA statement was released, the Mid America Heart and Vascular Institute (MAHVI) had implemented a depression screening protocol for patients with acute myocardial infarction that was virtually identical to the AHA recommendationsTo (1) evaluate this MAHVI quality improvement initiative, (2) compare MAHVI depression recognition rates with those of other hospitals, and (3) examine health care providers' implementation feedback, we compared the results of the MAHVI screening program with data from a parallel prospective acute myocardial infarction registry and interviewed MAHVI providersDepressive symptoms (PHQ-2, PHQ-9) were assessed among 503 MAHVI acute myocardial infarction patients and compared with concurrent depression assessments among 3533 patients at 23 US centers without a screening protocolA qualitative summary of providers' suggestions for improvement was also generatedA total of 135 (26.8%) eligible MAHVI patients did not get screenedAmong screened patients, 90.9% depressed (PHQ-9 >10) patients were recognizedThe agreement between the screening and registry data using the full PHQ-9 was 61.5% for positive cases (PHQ-9 >0) but only 35.6% for the PHQ-2 aloneAlthough MAHVI had a slightly higher overall depression recognition rate (38.3%) than other centers not using a depression screening protocol (31.5%), the difference was not statistically significant (p=0.31)Staff feedback suggested that a single-stage screening protocol with continuous feedback could improve complianceConclusions: In this early effort to implement a depression screening protocol, a large proportion of patients did not get screened, and only a modest impact on depression recognition rates was realizedSimplifying the protocol by using the PHQ-9 alone and providing more support and feedback may improve the rates of depression detection and treatment.

AB - Background: The American Heart Association (AHA) statement has recommended routine screening for depression in coronary artery disease with a 2-stage implementation of the Patient Health Questionnaire (PHQ)Because there is little evidence on feasibility, accuracy, and impact of such a program on depression recognition in coronary patients, the AHA recommendation has met substantial debate and criticismMethods and Results: Before the AHA statement was released, the Mid America Heart and Vascular Institute (MAHVI) had implemented a depression screening protocol for patients with acute myocardial infarction that was virtually identical to the AHA recommendationsTo (1) evaluate this MAHVI quality improvement initiative, (2) compare MAHVI depression recognition rates with those of other hospitals, and (3) examine health care providers' implementation feedback, we compared the results of the MAHVI screening program with data from a parallel prospective acute myocardial infarction registry and interviewed MAHVI providersDepressive symptoms (PHQ-2, PHQ-9) were assessed among 503 MAHVI acute myocardial infarction patients and compared with concurrent depression assessments among 3533 patients at 23 US centers without a screening protocolA qualitative summary of providers' suggestions for improvement was also generatedA total of 135 (26.8%) eligible MAHVI patients did not get screenedAmong screened patients, 90.9% depressed (PHQ-9 >10) patients were recognizedThe agreement between the screening and registry data using the full PHQ-9 was 61.5% for positive cases (PHQ-9 >0) but only 35.6% for the PHQ-2 aloneAlthough MAHVI had a slightly higher overall depression recognition rate (38.3%) than other centers not using a depression screening protocol (31.5%), the difference was not statistically significant (p=0.31)Staff feedback suggested that a single-stage screening protocol with continuous feedback could improve complianceConclusions: In this early effort to implement a depression screening protocol, a large proportion of patients did not get screened, and only a modest impact on depression recognition rates was realizedSimplifying the protocol by using the PHQ-9 alone and providing more support and feedback may improve the rates of depression detection and treatment.

KW - AHA medical/scientific statements

KW - Myocardial infarction

KW - Patient centered care

KW - Rrisk factors

UR - http://www.scopus.com/inward/record.url?scp=79959767400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959767400&partnerID=8YFLogxK

U2 - 10.1161/CIRCOUTCOMES.110.960013

DO - 10.1161/CIRCOUTCOMES.110.960013

M3 - Article

VL - 4

SP - 283

EP - 292

JO - Circulation: Cardiovascular Quality and Outcomes

JF - Circulation: Cardiovascular Quality and Outcomes

SN - 1941-7713

IS - 3

ER -